Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  EntreMed Inc    

ENTREMED INC
Mes dernières consult.
Most popular
  Report  
SummaryNewsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Develops pharmaceutical drugs for treating cancer and inflammatory diseases

CASI Pharmaceuticals, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs with commercial focus on the China market.

The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong and Macau.

The drugs are Captisol-Enabled, ZEVALIN and MARQIBO.

CASI Pharmaceuticals was founded in 1991 and is headquartered in Rockville, MD.
Managers
NameAgeSinceTitle
Ken Keyong Ren MD, PhD582012Chief Executive Officer & Director
Wei-Wu He PhD, MBA532012Executive Chairman
Cynthia Wong Hu482006COO, Secretary, Vice President & General Counsel
Sara B. Capitelli, CPA512011Chief Accounting Officer & Vice President-Finance
Alexander A. Zukiwski, MD602017Chief Medical Officer
Zuie Chin Huang, MBA522013Independent Director
Yue Wu PhD, MBA542013Independent Director
Franklin Cary Salisbury, Jr.622014Independent Director
Rajesh C. Shrotriya, MD742014Independent Director
Quan Zhou, PhD602016Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 86,158,177 50,039,498 58.1% 79,545 0.1% 58.1%
Shareholders
NameEquities%
IDG Capital Partners Co., Ltd. 11,625,221 16.6%
Spectrum Pharmaceuticals, Inc. 11,547,675 16.5%
Hexie Aiqi Investment Management Beijing Co., Ltd. 8,498,765 12.2%
Hung Ka Kung 6,296,292 9.01%
Emerging Technology Partners LLC 5,399,096 7.72%
Zhejiang Kanglaite Group Co. Ltd. 4,938,269 7.06%
The Vanguard Group, Inc. 926,844 1.33%
Wei-Wu He PhD, MBA 847,527 1.21%
Wellington Shields Capital Management LLC 725,348 1.04%
Wellington Shields & Co. LLC (Investment Management) 445,118 0.64%
Company contact information
CASI Pharmaceuticals, Inc.
9620 Medical Center Drive
Suite 300
Rockville, MD 20850

Phone : +1.240.864.2600
Fax : +1.240.315.2437
Web : www.casipharmaceuticals.com
Sector Biotechnology & Medical Research - NEC
1st jan.Capitalization (M$)
ENTREMED INC446
CELLTRION, INC.--.--%31 467
IQVIA HOLDINGS INC-0.64%20 258
LONZA GROUP-6.95%18 703
INCYTE CORPORATION-27.09%14 493
NEKTAR THERAPEUTICS44.36%13 873
ALNYLAM PHARMACEUTICALS, INC.-23.27%9 765
SEATTLE GENETICS, INC.-7.14%7 857
QIAGEN6.01%7 574
ALKERMES PLC-15.91%7 186
SAGE THERAPEUTICS INC-10.14%6 776
ICON PLC4.90%6 357
IONIS PHARMACEUTICALS INC-8.85%6 085
EXACT SCIENCES CORPORATION-10.93%5 747
BIO-TECHNE CORP17.48%5 725
PRA HEALTH SCIENCES INC-4.17%5 567
CHARLES RIVER LABORATORIES INTL. INC-3.65%5 057
GALAPAGOS-0.08%4 968
UNITED THERAPEUTICS CORPORATION-23.63%4 932
HANGZHOU TIGERMED CONSULTING CO LTD--.--%4 384
ABLYNX115.64%4 131
Connections : EntreMed Inc
The UNLV Foundation
MithraGen, Inc.
Circle Internet Financial Ltd.
Human Longevity, Inc.
Beijing Genetron Biotechnology Co. Ltd.
Emerging Technology Partners LLC
Superdata Software Holdings Ltd.
JHL Biotech, Inc.
Cs Family Trust
Wuhan Kindstar Co. Ltd.
IDG Capital Partners Co., Ltd.
CVie Therapeutics Co. Ltd.
American-Sino OB/GYN Hospital
Zenesis Ltd.
Intradigm Corp.
OMNI Pharmaceuticals (USA), Inc.
Shrotriya Family Foundation
Smooth Prosper Ltd.
Spectrum Pharmaceuticals Cayman LP
GenScript Corp.
OriGene Technologies, Inc.
KPCB China Fund II LP
WUPIMA, Inc.
IDG Technology Venture Investment III LLC
Creditease Holdings Cayman Ltd.
Beijing Genetron Health Gene Technology Co. Ltd.
MZ Investment Holdings Ltd.
Allos Therapeutics, Inc.
IDG Technology Venture Investments LP
National Foundation for Cancer Research
IDG Technology Venture Investment IV LLC
© 2018 People , Fundamentals and Ownership